Johanna Mylet
CIK 1765988 · Chief Financial Officer · last filed 2025-01-08
Johanna Mylet is a Chief Financial Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for PSTX, was dated Jan 8, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. (PSTX) Delisted | Chief Financial Officer | 0 | $9.50 | $0 | $0 | 9 | 2025-01-08 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-08 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | −254,852 | $0 | EDGAR |
| 2024-03-04 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | +62,652 | -$74.7K | EDGAR |
| 2023-03-02 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | +88,449 | -$23.1K | EDGAR |
| 2022-03-01 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2021-12-22 | Poseida Therapeutics, Inc. (PSTX) Delisted | Exer (M) | +5,716 | $9.1K | EDGAR |
| 2021-11-02 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-05 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-19 | Poseida Therapeutics, Inc. (PSTX) Delisted | Exer (M) | +4,728 | $1.4K | EDGAR |
| 2020-07-13 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |